{"id":"W3035432038","doi":"10.1016/s2468-1253(20)30188-6","title":"Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study","year":2020,"lang":"en","type":"article","venue":"˜The œLancet. Gastroenterology & hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":137,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"Celgene","keywords":"Medicine; Crohn's disease; Induction therapy; Blinded study; Clinical endpoint; Prospective cohort study; Internal medicine; Physical therapy; Disease; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002749647,0.001472022,0.00329881,0.0003017022,0.0003611613,0.00121692,0.0007154847,0.001399684,0.002959734],"category_scores_gemma":[0.002064528,0.0004526722,0.001375078,0.0004164874,0.001043236,0.00092627,0.0005078246,0.002100672,0.0006594745],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007417703,"about_ca_system_score_gemma":0.001136553,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004751468,"about_ca_topic_score_gemma":0.00101442,"domain_scores_codex":[0.9986959,0.0007848191,0.00007367278,0.0001501177,0.0001333314,0.0001620858],"domain_scores_gemma":[0.9982663,0.0004679495,0.0005084357,0.0001824234,0.0001545397,0.0004203609],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9830669,0.00313957,0.0009067648,0.0003585177,0.0004505557,0.00001557532,0.00002736843,0.0001925963,0.002255682,0.00004642837,0.0003037082,0.009236277],"study_design_scores_gemma":[0.8293932,0.1584832,0.008989168,0.00004252575,0.0007408479,0.00003916083,0.0000368351,0.0005905509,0.0007876995,0.0001369772,0.0007337505,0.00002605524],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906951,0.003229437,0.0008765005,0.000350877,0.0003039951,0.002066585,0.0009467835,0.00007210381,0.00145866],"genre_scores_gemma":[0.9913347,0.001563397,0.001486839,0.0005896898,0.0003060041,0.002241571,0.001026842,0.00001984379,0.001431123],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00329881,"threshold_uncertainty_score":0.01454175,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02961070197749057,"score_gpt":0.2700057253020772,"score_spread":0.2403950233245866,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}